Table 4.
Adjusted odds ratios (95% confidence interval) for dyslipidemia in adults according to the height percentile.
| Height percentile | P-for-trend | |||||
|---|---|---|---|---|---|---|
| <10th | 10–29th | 30–69th | 70–89th | ≥90th | ||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
| Men | ||||||
| TC ≥ 240 mg/dL | ||||||
| Model 1 | 1.91 (1.32–2.74) | 2.01 (1.44–2.81) | 1.54 (1.13–2.12) | 1.53 (1.11–2.12) | ref | <0.001 |
| Model 2 | 1.84 (1.23–2.74) | 1.87 (1.31–2.69) | 1.51 (1.09–2.11) | 1.51 (1.09–2.11) | ref | 0.004 |
| HDL-C < 40 mg/dL | ||||||
| Model 1 | 1.27 (1.04–1.56) | 1.17 (0.98–1.40) | 1.14 (0.97–1.34) | 1.04 (0.87–1.23) | ref | 0.045 |
| Model 2 | 1.50 (1.19–1.89) | 1.29 (1.05–1.58) | 1.26 (1.04–1.51) | 1.12 (0.93–1.36) | ref | 0.003 |
| TG ≥ 200 mg/dL | ||||||
| Model 1 | 1.58 (1.27–1.96) | 1.50 (1.24–1.82) | 1.27 (1.07–1.52) | 1.12 (0.92–1.36) | ref | <0.001 |
| Model 2 | 1.85 (1.44–2.38) | 1.64 (1.32–2.05) | 1.37 (1.12–1.68) | 1.18 (0.94–1.47) | ref | <0.001 |
| LDL-C ≥ 160 mg/dL | ||||||
| Model 1 | 1.52 (1.05–2.21) | 1.61 (1.17–2.21) | 1.47 (1.08–1.99) | 1.25 (0.90–1.73) | ref | 0.001 |
| Model 2 | 1.56 (1.05–2.32) | 1.60 (1.14–2.27) | 1.51 (1.10–2.07) | 1.28 (0.92–1.78) | ref | 0.026 |
| Dyslipidemia | ||||||
| Model 1 | 1.69 (1.41–2.02) | 1.51 (1.29–1.76) | 1.33 (1.15–1.54) | 1.16 (0.99–1.36) | ref | <0.001 |
| Model 2 | 1.93 (1.57–2.39) | 1.62 (1.35–1.93) | 1.44 (1.22–1.70) | 1.26 (1.05–1.47) | ref | <0.001 |
| Women | ||||||
| LDL-C ≥ 160 mg/dL | ||||||
| Model 1 | 6.76 (3.75–12.2) | 4.75 (2.67–8.45) | 3.50 (1.96–6.25) | 2.22 (1.22–4.05) | ref | <0.001 |
| Model 2 | 2.61 (1.41–4.81) | 2.12 (1.17–3.84) | 2.01 (1.11–3.63) | 1.64 (0.89–3.02) | ref | <0.001 |
| HDL-C < 40 mg/dL | ||||||
| Model 1 | 1.48 (0.99–2.21) | 1.56 (1.05–2.33) | 1.22 (0.83–1.79) | 0.99 (0.66–1.46) | ref | <0.001 |
| Model 2 | 1.33 (0.86–2.04) | 1.54 (1.02–2.33) | 1.28 (0.86–1.91) | 1.12 (0.74–1.68) | ref | 0.003 |
| TG ≥ 200 mg/dL | ||||||
| Model 1 | 2.24 (1.40–3.60) | 1.99 (1.26–3.13) | 1.39 (0.89–2.19) | 1.11 (0.69–1.77) | ref | <0.001 |
| Model 2 | 1.34 (0.78–2.31) | 1.35 (0.81–2.29) | 1.11 (0.67–1.85) | 1.06 (0.63–1.79) | ref | 0.087 |
| LDL-C ≥ 160 mg/dL | ||||||
| Model 1 | 4.70 (2.64–8.33) | 3.62 (2.06–6.35) | 2.64 (1.50–4.64) | 1.57 (0.87–2.83) | ref | <0.001 |
| Model 2 | 1.84 (1.03–3.30) | 1.71 (0.97–3.01) | 1.52 (0.87–2.67) | 1.19 (0.66–2.13) | ref | 0.002 |
| Dyslipidemia | ||||||
| Model 1 | 3.09 (2.27–4.20) | 2.49 (1.85–3.36) | 1.80 (1.34–2.40) | 1.24 (0.92–1.68) | ref | <0.001 |
| Model 2 | 1.88 (1.35–2.61) | 1.79 (1.31–2.45) | 1.52 (1.12–2.06) | 1.27 (0.93–1.73) | ref | <0.001 |
Model 1: Unadjusted.
Model 2: Adjusted for age, waist circumference, systolic/diastolic blood pressure, fasting glucose levels, household income, physical activity, alcohol consumption, and menopause status (for women).
CI, confidence interval; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; OR, odd ratio; TC, total cholesterol; TG, triglycerides.